Mancinelli A, D'Aranno V, Stasi M A, Lecci A, Borsini F, Meli A
Menarini Ricerche Sud, Roma, Italy.
Pharmacol Res. 1991 Jan;23(1):47-50. doi: 10.1016/s1043-6618(05)80105-7.
The effect of d- and l-enantiomers of propranolol on desipramine-induced anti-immobility effects and on brain desipramine levels was studied in the rat. Intraperitoneal propranolol and desipramine were administered three times, 25, 6, 2 and 24, 5, 1 h respectively, before the test. It was found that l-propranolol but not d-propranolol, at the same doses (2.5 and 5 mg/kg), antagonized 20 mg/kg desipramine without altering desipramine brain levels. It is suggested that blockade of beta-adrenergic receptors rather than membrane-stabilizing or pharmacokinetic effects is responsible for the antagonism of propranolol toward desipramine.
在大鼠中研究了普萘洛尔的右旋和左旋对映体对去甲丙咪嗪诱导的抗不动效应以及对脑内去甲丙咪嗪水平的影响。在测试前分别于25、6、2小时和24、5、1小时腹腔注射普萘洛尔和去甲丙咪嗪三次。结果发现,相同剂量(2.5和5mg/kg)的左旋普萘洛尔而非右旋普萘洛尔可拮抗20mg/kg去甲丙咪嗪,且不改变脑内去甲丙咪嗪水平。提示普萘洛尔对去甲丙咪嗪的拮抗作用是由β-肾上腺素能受体阻断而非膜稳定或药代动力学效应所致。